Dominik Höchli
Directeur/Bestuurslid bij MOLECULAR PARTNERS AG
Actieve functies van Dominik Höchli
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Bestuurslid | 21-04-2021 | - |
| Independent Dir/Board Member | 21-04-2021 | - | |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Algemeen Directeur | 01-01-2021 | - |
Loopbaan van Dominik Höchli
Eerdere bekende functies van Dominik Höchli
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - | - |
Opleiding van Dominik Höchli
| University of Bern | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 4 |
| Nederland | 2 |
Operationeel
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
| AbbVie AG |
- Beurs
- Insiders
- Dominik Höchli
- Ervaring
